Published in Arterioscler Thromb Vasc Biol on March 31, 2011
Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res (2011) 1.70
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res (2012) 1.45
Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int (2013) 1.29
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol (2014) 1.21
Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol (2012) 1.20
Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation (2012) 1.11
RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. J Vasc Res (2012) 0.96
Serum response factor regulates bone formation via IGF-1 and Runx2 signals. J Bone Miner Res (2012) 0.95
Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus. Circ Res (2014) 0.95
Mechanisms of arterial calcifications and consequences for cardiovascular function. Kidney Int Suppl (2011) (2013) 0.93
Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus. Arterioscler Thromb Vasc Biol (2016) 0.92
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. PLoS One (2013) 0.91
Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway. PLoS One (2012) 0.90
Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol (2014) 0.90
The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One (2014) 0.89
Vascular calcification and renal bone disorders. ScientificWorldJournal (2014) 0.88
Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model. Atherosclerosis (2014) 0.87
Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells. Cardiovasc Res (2015) 0.85
Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor. Stem Cells Dev (2013) 0.85
Vascular calcification: harder than it looks. Arterioscler Thromb Vasc Biol (2011) 0.84
Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature. Curr Osteoporos Rep (2015) 0.84
MicroRNAs Regulate Vascular Medial Calcification. Cells (2014) 0.83
Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. PLoS One (2013) 0.82
Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice. Atherosclerosis (2015) 0.82
Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. J Vasc Res (2014) 0.81
Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells. Redox Biol (2016) 0.81
Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association. Bone (2015) 0.81
Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. Stem Cells Dev (2014) 0.80
Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice. Calcif Tissue Int (2012) 0.79
Vascular calcification, diabetes, and cardiovascular disease: connecting the dots. JACC Cardiovasc Imaging (2012) 0.79
Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity. J Transl Med (2013) 0.79
Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia. Int J Med Sci (2014) 0.77
Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation. J Bone Miner Res (2013) 0.76
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int (2013) 0.76
RUNX2 Mutation Impairs 1α,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells. Sci Rep (2016) 0.75
The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis inducing ligand. J Biol Chem (2017) 0.75
Evidence for constitutive bone morphogenetic protein-2 secretion by M1 macrophages: Constitutive auto/paracrine osteogenic signaling by BMP-2 in M1 macrophages. Biochem Biophys Res Commun (2017) 0.75
Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice. J Cell Biochem (2017) 0.75
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (1998) 8.92
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
Role of oxidative modifications in atherosclerosis. Physiol Rev (2004) 6.73
Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest (1993) 4.54
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res (2001) 3.50
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2001) 2.93
Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med (2001) 2.79
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem (2008) 2.55
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev (2004) 2.35
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol (2004) 2.23
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res (2009) 2.17
Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab (2004) 2.14
Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem (2001) 2.02
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol (2006) 1.86
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem (2005) 1.81
Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation (2009) 1.65
Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem (2005) 1.59
Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J Bone Miner Res (2008) 1.53
Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol (2008) 1.51
cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem (1998) 1.38
Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci (2007) 1.37
Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription. Mol Cell Biol (2006) 1.36
Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J (2002) 1.32
Biology of the TRANCE axis. Cytokine Growth Factor Rev (2003) 1.29
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res (2005) 1.26
Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res (2007) 1.23
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin Exp Metastasis (2006) 1.17
Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research. Curr Atheroscler Rep (2002) 1.14
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men. Circulation (2003) 1.09
Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch (1998) 1.08
Effect of calcification on in vivo mechanical response of rabbit arteries to balloon dilation. Circulation (1991) 1.06
Role of pericytes in vascular calcification: a review. Z Kardiol (2000) 1.04
The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes. FASEB J (2003) 1.02
Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. J Cell Biochem (2006) 0.98
Receptor activator of NF-kappaB ligand enhances the activity of macrophages as antigen presenting cells. Exp Mol Med (2005) 0.96
A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. J Biol Chem (2004) 0.93
Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem (2005) 0.91
Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Biochem Biophys Res Commun (2004) 0.88
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. J Cell Physiol (2006) 0.86
Regulation of RANKL-induced osteoclastic differentiation by vascular cells. J Mol Cell Cardiol (2005) 0.86
Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells. Endocrine (2007) 0.85
Role of Cbfa1/Runx2 in the fluid shear stress induction of COX-2 in osteoblasts. Biochem Biophys Res Commun (2006) 0.83
Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis (1996) 0.83
Mechanical loading differentially regulates membrane-bound and soluble RANKL availability in MC3T3-E1 cells. Ann N Y Acad Sci (2006) 0.78
Plant species richness and ecosystem multifunctionality in global drylands. Science (2012) 5.57
Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol (2004) 4.02
Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 3.64
Epitaxial core-shell and core-multishell nanowire heterostructures. Nature (2002) 3.39
Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity (2009) 3.32
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem (2008) 2.55
Decoupling of soil nutrient cycles as a function of aridity in global drylands. Nature (2013) 2.50
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol (2006) 2.22
Regulatory mechanisms in vascular calcification. Nat Rev Cardiol (2010) 2.22
Multilineage potential of cells from the artery wall. Circulation (2003) 2.17
Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation (2011) 1.99
Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr (2011) 1.93
Nanowire crossbar arrays as address decoders for integrated nanosystems. Science (2003) 1.72
Monocyte/macrophage regulation of vascular calcification in vitro. Circulation (2002) 1.67
A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet (2006) 1.63
Direct heteroepitaxy of vertical InAs nanowires on Si substrates for broad band photovoltaics and photodetection. Nano Lett (2009) 1.60
Pitting phosphate transport inhibitors against vascular calcification. Circ Res (2006) 1.59
Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery. Pediatr Crit Care Med (2012) 1.57
Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol (2003) 1.56
Pattern formation by vascular mesenchymal cells. Proc Natl Acad Sci U S A (2004) 1.54
Mesenchymal stem cells and the artery wall. Circ Res (2004) 1.52
Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res (Hoboken) (2010) 1.48
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res (2012) 1.45
Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J (2003) 1.41
Asymmetric cryorolling for fabrication of nanostructural aluminum sheets. Sci Rep (2012) 1.41
In-vivo corrosion and local release of metallic ions from vascular stents into surrounding tissue. J Invasive Cardiol (2010) 1.40
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant (2004) 1.39
Drug-loaded, magnetic, hollow silica nanocomposites for nanomedicine. Nanomedicine (2005) 1.38
Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest (2007) 1.36
Rational synthesis of p-type zinc oxide nanowire arrays using simple chemical vapor deposition. Nano Lett (2007) 1.30
Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol (2003) 1.29
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem (2002) 1.26
Nanowire photodetectors. J Nanosci Nanotechnol (2010) 1.23
High-density lipoprotein regulates calcification of vascular cells. Circ Res (2002) 1.22
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol (2014) 1.21
Precise semiconductor nanowire placement through dielectrophoresis. Nano Lett (2009) 1.21
Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol (2007) 1.21
Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology (2008) 1.20
FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J Clin Invest (2003) 1.18
Fabrication of ultra-thin nanostructured bimetallic foils by Accumulative Roll Bonding and Asymmetric Rolling. Sci Rep (2013) 1.18
Mechanical stress analysis of a rigid inclusion in distensible material: a model of atherosclerotic calcification and plaque vulnerability. Am J Physiol Heart Circ Physiol (2009) 1.18
Air puff induced corneal vibrations: theoretical simulations and clinical observations. J Refract Surg (2014) 1.16
A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials (2009) 1.15
Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun (2008) 1.15
GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol (2004) 1.12
Endothelial cell dynamics under pulsating flows: significance of high versus low shear stress slew rates (d(tau)/dt). Ann Biomed Eng (2002) 1.10
Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunol (2009) 1.09
Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens (2011) 1.09
Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One (2011) 1.09
Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year. Neurosurgery (2009) 1.08
African ancestry is associated with asthma risk in African Americans. PLoS One (2012) 1.07
High electron mobility InAs nanowire field-effect transistors. Small (2007) 1.07
Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clin Chim Acta (2010) 1.06
Analysis of expressed sequence tags from the Huperzia serrata leaf for gene discovery in the areas of secondary metabolite biosynthesis and development regulation. Physiol Plant (2009) 1.06
Group for research in pathology education online resources to facilitate pathology instruction. Arch Pathol Lab Med (2002) 1.06
A conserved domain of previously unknown function in Gap1 mediates protein-protein interaction and is required for biogenesis of a serine-rich streptococcal adhesin. Mol Microbiol (2008) 1.03
Quality of life evaluation of maxillomandibular advancement surgery for treatment of obstructive sleep apnea. J Oral Maxillofac Surg (2008) 1.02
Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin. PLoS Biol (2009) 1.02
Left-right symmetry breaking in tissue morphogenesis via cytoskeletal mechanics. Circ Res (2012) 1.02
Adverse effects of hyperlipidemia on bone regeneration and strength. J Bone Miner Res (2012) 1.01
Perinatal tobacco smoke exposure increases vascular oxidative stress and mitochondrial damage in non-human primates. Cardiovasc Toxicol (2010) 1.01
A systematic study on the growth of gaas nanowires by metal-organic chemical vapor deposition. Nano Lett (2008) 1.01
Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res (2011) 1.00
Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens (2002) 1.00
Angioarchitectural characteristics of brain arteriovenous malformations with and without hemorrhage. World Neurosurg (2011) 1.00
The effect of plasminogen activator inhibitor type 1 on apoptosis. Thromb Haemost (2008) 0.99
Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics (2011) 0.99
Bone density and hyperlipidemia: the T-lymphocyte connection. J Bone Miner Res (2010) 0.99
Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts. J Biol Chem (2007) 0.98
Electrochemical energy storage by polyaniline nanofibers: high gravity assisted oxidative polymerization vs. rapid mixing chemical oxidative polymerization. Phys Chem Chem Phys (2014) 0.98
Protective effect of electroacupuncture and moxibustion on gastric mucosal damage and its relation with nitric oxide in rats. World J Gastroenterol (2000) 0.97
Metformin impairs the growth of liver kinase B1-intact cervical cancer cells. Gynecol Oncol (2012) 0.97
Plants can benefit from herbivory: stimulatory effects of sheep saliva on growth of Leymus chinensis. PLoS One (2012) 0.96
The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification. Circ Res (2011) 0.96
Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res (2008) 0.96